New Zealand markets closed

Astellas Pharma Inc. (YPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
8.99+0.10 (+1.08%)
As of 09:17AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 16.49B
Enterprise value 19.67B
Trailing P/E 163.74
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.74
Price/book (mrq)1.74
Enterprise value/revenue 2.14
Enterprise value/EBITDA 17.62

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 3-31.77%
S&P500 52-week change 325.87%
52-week high 314.31
52-week low 38.47
50-day moving average 38.89
200-day moving average 310.19

Share statistics

Avg vol (3-month) 3288
Avg vol (10-day) 3N/A
Shares outstanding 51.79B
Implied shares outstanding 61.85B
Float 81.73B
% held by insiders 10.25%
% held by institutions 151.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.45
Forward annual dividend yield 45.01%
Trailing annual dividend rate 370.00
Trailing annual dividend yield 3787.40%
5-year average dividend yield 42.83
Payout ratio 4739.18%
Dividend date 3N/A
Ex-dividend date 427 Sept 2024
Last split factor 25:1
Last split date 327 Mar 2014

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.06%
Operating margin (ttm)14.41%

Management effectiveness

Return on assets (ttm)2.58%
Return on equity (ttm)1.10%

Income statement

Revenue (ttm)1.6T
Revenue per share (ttm)894.27
Quarterly revenue growth (yoy)17.00%
Gross profit (ttm)N/A
EBITDA 282.45B
Net income avi to common (ttm)17.05B
Diluted EPS (ttm)0.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)364.47B
Total cash per share (mrq)203.26
Total debt (mrq)1.01T
Total debt/equity (mrq)63.15%
Current ratio (mrq)0.93
Book value per share (mrq)890.07

Cash flow statement

Operating cash flow (ttm)172.48B
Levered free cash flow (ttm)143.67B